Position in BDSX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$655,849
New position
Shares Held
45,231
first reported quarter
Ownership
0.447%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 40 holders
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $1,108,346,968 across 33 Diagnostics & Research names. BDSX ranks #25 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
4,229,531 | $390,681,778 | |
| 2 | DHR |
Danaher Corp /De/
|
1,858,782 | $352,425,067 | |
| 3 | TMO |
Thermo Fisher Scientific Inc.
|
187,893 | $92,355,046 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
176,557 | $84,780,905 | |
| 5 | A |
Agilent Technologies, Inc.
|
677,347 | $77,204,011 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
219,984 | $37,516,071 | |
| 7 | ILMN |
Illumina, Inc.
|
73,717 | $9,086,357 | |
| 8 | NTRA |
Natera, Inc.
|
40,200 | $8,039,598 |
All Filings in BDSX
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $655,849 | 45,231 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||